Capital Market Strategies’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,161
| Closed | -$358K | – | 150 |
|
|
2025
Q1 | $358K | Sell |
5,161
-936
| -15% | -$65K | 0.24% | 82 |
|
|
2024
Q4 | $524K | Sell |
6,097
-3,797
| -38% | -$327K | 0.3% | 68 |
|
|
2024
Q3 | $1.18M | Buy |
9,894
+150
| +2% | +$17.9K | 0.71% | 29 |
|
|
2024
Q2 | $1.39M | Sell |
9,744
-99
| -1% | -$14.1K | 0.88% | 24 |
|
|
2024
Q1 | $1.26M | Buy |
9,843
+679
| +7% | +$87.2K | 0.96% | 23 |
|
|
2023
Q4 | $948K | Buy |
9,164
+1,158
| +14% | +$120K | 0.83% | 25 |
|
|
2023
Q3 | $703K | Buy |
8,006
+1,322
| +20% | +$116K | 0.7% | 31 |
|
|
2023
Q2 | $541K | Buy |
+6,684
| New | +$541K | 0.5% | 50 |
|
|
2023
Q1 | – | Sell |
-3,850
| Closed | -$261K | – | 102 |
|
|
2022
Q4 | $261K | Buy |
+3,850
| New | +$261K | 0.28% | 99 |
|